https://orcid.org/0000-0003-3864-1818
References
- WHO Coronavirus (COVID-19) Dashboard n.d. accessed June 21, 2022. https://covid19.who.int
- MoHFW | Home n.d. https://www.mohfw.gov.in/accessed June 21, 2022.
- Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nature Med. 2020; 26(7):1017–7. DOI:10.1038/s41591-020-0968-3
- Kassebaum NJ, Barber RM, Bhutta ZA, et al. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016; 388 (10053):1775–1812. DOI:10.1016/S0140-6736(16)31470-2
- Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG Int J Obstet Gynaecol. 2020; 127 (11):1374–1380. DOI:10.1111/1471-0528.16339
- Lai J, Romero R, Tarca AL, et al. SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality. Am J Clin Exp Obstet Gynecol. 2021; 225 (6):689–693.e1. DOI:10.1016/j.ajog.2021.08.020
- Papageorghiou AT, Deruelle P, Gunier RB, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Clin Exp Obstet Gynecol. 2021; 225 (3): 289.e1-289.e17. DOI:10.1016/j.ajog.2021.05.014.
- Mahajan NN, Pednekar R, Patil SR, et al. Preparedness, administrative challenges for establishing obstetric services, and experience of delivering over 400 women at a tertiary care COVID-19 hospital in India. Int J Gynecol Obstet. 2020; 151 (2):188–196. DOI:10.1002/ijgo.13338
- Testing Strategy n.d. https://www.icmr.gov.in/cteststrat.html accessed June 14, 2022.
- UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.Pdf, (n.d.). https://www.Mohfw.gov.in/pdfUpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.Pdf accessed June 14, 2022.
- Mahajan NN, Pophalkar M, Patil S, et al. Pregnancy outcomes and maternal complications during the second wave of Coronavirus Disease 2019 (COVID-19) in India. Obstet Gynaecol. 2021; 138 (4):660–662. DOI:10.1097/AOG.0000000000004529
- Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: iSSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018; 13:291–310.
- Illi B, Vasapollo B, Valensise H, et al. SARS-CoV-2, endothelial dysfunction, and the Renin-Angiotensin System (RAS): a potentially dangerous triad for the development of pre-Eclampsia. Reprod Med. 2021; 2 (2):95–106.
- Lumbers ER, Delforce SJ, Arthurs AL, et al. Causes and consequences of the dysregulated Maternal Renin-Angiotensin System in Preeclampsia. Front Endocrinol. 2019; 10:563.
- Agrawal S, Walia GK, Staines-Urias E, et al. Prevalence of and risk factors for eclampsia in pregnant women in India. Fam Med Com Health. 2017; 5 (4):225.
- Zhao P, Praissman JL, Grant OC, et al. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor. Cell Host Microbe. 2020; 28 (4):586–601.e6. DOI:10.1016/j.chom.2020.08.004
- Shauly-Aharonov M, Shafrir A, Paltiel O, et al. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: new insights from a population-based study. PLoS ONE. 2021; 16 (7):e0254847. DOI:10.1371/journal.pone.0254847
- Swaminathan G, Swaminathan A, Corsi DJ. Prevalence of gestational diabetes in India by individual socioeconomic, demographic, and clinical factors. JAMA Netw Open. 2020; 3 (11):e2025074.
- Kadiwar S, Smith JJ, Ledot S, et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet. 2021; 397 (10284):1539–1540. DOI:10.1016/S0140-6736(21)00716-9